Navigation Links
Solta Medical Announces Isolaz 2 Acne System
Date:6/3/2013

HAYWARD, Calif., June 3, 2013 /PRNewswire/ -- Solta Medical, Inc. (Nasdaq: SLTM), the global market leader in aesthetic skin treatments, today announced Isolaz® 2, the next generation acne therapy device. Isolaz 2 effectively targets the root causes of acne through a unique, clinically proven combination of vacuum extraction for deep pore purification, broadband light to destroy acne causing bacteria, and a profusion mode to enhance the delivery of topicals into the skin.

"The Isolaz technology is an invaluable tool that sets me apart as a skin specialist; these days, patients want non-systemic and no downtime yet effective acne treatments and Isolaz technology offers all of the above," said Dr. Kenneth Beer , MD., PA., founder of Kenneth Beer MD PA,  General, Cosmetic And Surgical Dermatology and voluntary assistant professor at the University of Miami and a consulting associate in the Department of Medicine at Duke University. "The new disposable tips in a variety of sizes offer more options for speed, safety and comfort, expanding treatment area options to include the face, back and chest. With the Isolaz 2 system, physicians can offer safe acne treatments for individual patient needs. I have used the Isolaz technology with great efficacy on many of my patients as well as on my sons."

Isolaz 2 uses Intense Pulsed Light (IPL) therapy combined with vacuum technology clinical proven to safely and effectively treat acne in a three-step process – Cleanse, Purify, Replenish. First, a vacuum removes sebaceous materials to cleanse the pores; second, broadband light purifies by destroying acne-causing bacteria; third, skincare topicals are infused into the skin for a replenishing effect. Isolaz 2 treatment tips come in small, medium and large sizes along with various lamp filters, allowing physicians to customize treatments to their patients' needs. The disposable, "treat and toss" tips and profusion applicators are hygienic, reduce possible risks of contamination and minimize post-treatment cleanup.

"We are very excited about the expanded options Isolaz 2 creates for both physician and patients," said Stephen J. Fanning , Chairman of the Board, President and CEO of Solta Medical, Inc. "Isolaz 2 is a fast, comfortable and non-systemic way to treat acne for almost immediate results and fewer breakouts over time. The profusion treatments allow for topical infusion, and Isolaz 2 is safe for all skin types, setting it apart from competitors."

Clinical studies have shown drying and flattening of lesions within 24-48 hours post treatment.1 Patients have seen a decrease in the amount of oil production starting after the first treatment, and also a significant decrease in number, frequency and severity of "break-outs."2 Additionally, non-responders to orals, topicals and lasers experienced over a 75% reduction in lesions within two months.2

For more information about Isolaz 2, please visit http://isolaz.com/

ABOUT SOLTA MEDICAL, INC.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin tightening, as well as tools and accessories to optimize the latest liposuction techniques. Each brand is an established category leader, and together comprise of a comprehensive platform to address a range of aesthetic skin and body issues. Fraxel® delivers minimally-invasive clinical solutions to resurface aging and sun damaged skin. Clear + Brilliant® is a cost-effective, non-ablative laser treatment uniquely designed to improve skin tone and radiance. Isolaz® acne treatment combines vacuum and painless broadband light to address a wide variety of acne types. CLARO® is an FDA-cleared personal care acne device that uses heat and light to clear skin quickly and naturally. Thermage® is a non-invasive radiofrequency procedure that improves the appearance of wrinkles, which can result in smoother, more contoured skin. Liposonix® is a non-surgical single-treatment procedure that uses advanced high-intensity focused ultrasound technology to destroy targeted fat beneath the skin. VASERshape is a complementary non-invasive treatment that combines low frequency, non-focused ultrasound and lymphatic massage to temporarily reduce the appearance of cellulite and improve blood circulation with minimal pain or no downtime. The VASERlipo system uses ultrasound technology to selectively remove unwanted body fat. It includes VentX® technology that powers an aspiration system for quiet, efficient removal of fatty tissue and precision vented cannulas to maximize aspiration efficiency and speed. VASERsmooth is a unique body sculpting add-on tool for use with the VASERlipo system. PowerX® is a power-assisted liposuction system that uses a unique rotational motion which can be used with the VASERlipo system or to enhance traditional liposuction systems. The TouchView® system fits between the fingers and provides diagnostic imaging of subcutaneous structures during procedures. Both the VASERlipo system and traditional liposuction systems can utilize the Origins products, a complete line of custom liposuction infiltration, re-injection and aspiration cannulas and accessories. More than two and a half million procedures have been performed with Solta Medical's portfolio of products around the world.

For more information about Solta, call 1-877-782-2286 or log on to www.Solta.com.

1 Multi-Center data presented to the FDA, July 2006. Aesthera Corporation.

2 Shamban, Ava T., MD. Photopneumatic (PPx) Pore-Cleansing Acne Treatment: A Breakthrough Treatment Option for Non- Responders to Acne Therapies. White Paper. August 2006


'/>"/>
SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc.
2. Solta Medical Reports First Quarter 2013 Results
3. Solta Medical to Present at the 25th Annual ROTH Growth Stock Conference on March 18, 2013
4. Solta Medical Reports Fourth Quarter and Full Year 2012 Results
5. Solta Medical to Report Fourth Quarter 2012 Results Release and Host Conference Call on February 19, 2013
6. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
7. Solta Medical to Acquire Sound Surgical Technologies
8. Solta Medical Reports Third Quarter Results
9. Solta Medical And BTL Industries Resolve Patent Dispute
10. Solta Medical to Present at the 32nd Annual Canaccord Growth Conference
11. Solta Medical, Inc. Closes Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):